US4960416A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Dosage form with improved delivery capability
Assignee: Alza Corp
•
Filing: 1989-07-10
•
Granted: 1990-10-02
•
Expires: 2009-07-10
Abstract
Abstract A dosage form is disclosed comprising a wall surrounding a compartment housing a first layer comprising a drug formulation, a middle layer comprising a hydrophobic composition, and a third layer comprising a hydrophilic composition.
Inventors
- 👤 Sally I. Stephens
- 👤 Patrick S. L. Wong
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 20:48
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0004
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
199 words
A dosage form for delivering a beneficial agent to a fluid environment of use, comprising: (a) a wall comprising in at least a part a semipermeable composition permeable to the passage of an exterior aqueous fluid and substantially impermeable to the passage of a beneficial agent, which wall surrounds and forms: (b) a compartment; (c) a first layer comprising a beneficial agent in the compartment, which layer forms in situ a dispensable aqueous formulation with fluid that enters the compartment; (d) a third layer comprising means for expanding and occupying space in the presence of fluid in the compartment; (e) a second layer interposed between the first and third layer in the compartment, said second layer a separate and distinct layer comprising a different composition than the first and third layers, which second layer comprises a non-expandable hydrophobic composition that is a means for substantially preventing the migration of the beneficial agent from the first layer comprising the dispensable aqueous formulation into the third layer; and, (f) means in the wall connecting the exterior of the dosage form with the compartment, said means for connecting the exterior of the dosage form with the interior compartment comprising a microporous member.
Claim 2
Dependent Claim
199 words
A dosage form for delivering a beneficial agent to a fluid environment of use, comprising: (a) a wall comprising in at least a part a semipermeable composition permeable to the passage of an exterior aqueous fluid and substantially impermeable to the passage of a beneficial agent, which wall surrounds and forms: (b) a compartment; (c) a first layer comprising a beneficial agent in the compartment, which layer forms in situ a dispensable aqueous formulation with fluid that enters the compartment; (d) a third layer comprising means for expanding and occupying space in the presence of fluid in the compartment; (e) a second layer interposed between the first and third layer in the compartment, said second layer a separate and distinct layer comprising a different composition than the first and third layers, which second layer comprises a non-expandable hydrophobic composition that is a means for substantially preventing the migration of the beneficial agent from the first layer comprising the dispensable aqueous formulation into the third layer; and, (f) means in the wall connecting the exterior of the dosage form with the compartment, said means for connecting the exterior of the dosage form with the interior compartment comprising a microporous member.
Claim 3
Dependent Claim
43 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein when the dosage form is in operation the second layer adapts a shaped surface corresponding to the shaped surface of an expanding third layer.
Claim 4
Dependent Claim
54 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the second layer comprises a surface in contact with a surface of the third layer, which surfaces maintain their physical and chemical integrity essentially free from precipitation during the beneficial agent delivery period of time.
Claim 5
Dependent Claim
32 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the beneficial agent is poorly soluble in the means comprising the second layer.
Claim 6
Dependent Claim
35 words
The dosage form for delivering the beneficial agent to an aqueous fluid environment of use according to claim 1, wherein the second layer is independent and moves concomitantly with a moving first and third layer.
Claim 7
Dependent Claim
28 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the second layer means comprises a hydrophobic polymeric composition.
Claim 8
Dependent Claim
35 words
The dosage form for delivering the beneficial agent to a fluid environment of use according to claim 1, wherein the beneficial agent is poorly soluble in the second layer means comprising a hydrophobic polymeric composition.
References Cited (Backward Citations)
US3732865A
Cited
US3760805A
Cited
US3929132A
Cited
US3995632A
Cited
US4111202A
Cited
US4111201A
Cited
US4309996A
Cited
US4320759A
Cited
US4327725A
Cited
US4612008A
Cited
US4612186A
Cited
US4624945A
Cited
US4608048A
Cited
GB2179252A
Cited
US4863456A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-10-01 | 1994-04-02 | 1994-10-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-10-01 | 1998-04-02 | 1998-10-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-10-01 | 2002-04-02 | 2002-10-02 | $7700.00 | Window Closed / Lapsed |